Regen BioPharma Inc Annual Revenues in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Regen BioPharma Inc quarterly/annual Revenues history and growth rate from 2014 to 2023.
  • Regen BioPharma Inc Revenues for the quarter ending June 30, 2024 was $59.1K, unchanged year-over-year.
  • Regen BioPharma Inc Revenues for the twelve months ending June 30, 2024 was $127K, a 17.8% decline year-over-year.
  • Regen BioPharma Inc annual Revenues for 2023 was $127K, a 0.83% increase from 2022.
  • Regen BioPharma Inc annual Revenues for 2022 was $126K, a 105% increase from 2021.
  • Regen BioPharma Inc annual Revenues for 2021 was $61.2K, a 44.4% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $127K +$1.04K +0.83% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-20
2022 $126K +$64.3K +105% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-20
2021 $61.2K -$48.8K -44.4% Oct 1, 2020 Sep 30, 2021 10-K 2022-11-15
2020 $110K $0 0% Oct 1, 2019 Sep 30, 2020 10-K 2021-08-04
2019 $110K +$10K +10% Oct 1, 2018 Sep 30, 2019 10-K 2021-08-04
2018 $100K -$10K -9.09% Oct 1, 2017 Sep 30, 2018 10-K 2021-06-21
2017 $110K +$10K +10% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-27
2016 $100K -$92K -47.9% Oct 1, 2015 Sep 30, 2016 10-K 2016-12-21
2015 $192K +$192K Oct 1, 2014 Sep 30, 2015 10-K 2016-12-21
2014 $0 Oct 1, 2013 Sep 30, 2014 10-K/A 2017-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.